The American Council of Cannabis Medicine (ACCM) announced its proposed draft federal legislation and the start of discussions with sponsors in the House and Senate. ACCM leadership expects to onboard initial sponsors and advance the medical-cannabis legislative package at the start of the 2022 Congressional calendar.
"Legislative work accelerated this year. ACCM's continued focus on professionalization, clinical research, and greater access has been a rallying cry to align some of the best stakeholders in medical cannabis. The ongoing input is creating a path to finally bring movement on the federal level," says Mark Block, Co-Chair of ACCM's Legislative Committee. "Our legislative team, working hand-in-hand with an advocacy team, has put it all together for a successful legislative campaign. Everyone now sees a path forward for rescheduling medical cannabis."
Designed to bring massive public support for upcoming proposed legislation, the American Council of Cannabis Medicine's ongoing Citizen's Advocacy programs — Senior Source, We Care-We Cann, and Physicians Care — are running underneath the fully operating Yes We Cann! and Elevated States initiatives.
"We've been overwhelmed by how popular the topic of medical cannabis is. In a little over a month, we've aligned thousands who will support our effort nationally and within 50 state programs (including those yet to legalize)," says Glen Caroline, Head of Advocacy and ACCM Outreach Committee Co-Chair. "By the time the legislative process starts, ACCM will have built one of the largest and most engaged supporter groups in the country. Our team has worked on multiple campaigns, and rarely have we seen interest and support like this."
ACCM has aligned over 100 partner/professional resources to successfully navigate the legislative process.
For more information:
American Council of Cannabis Medicine